Age: 70.0
Sex: F
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Alopecia, Bedridden, Blood test normal, Influenza like illness, Malaise
Clinical narrative: This case was reported by a consumer via call center representative and described the occurrence of fever in a 70-year-old female patient who received SHINGRIX for prophylaxis. On 2nd April 2018, the patient received the 1st dose of SHINGRIX. In April 2018, less than a day after receiving SHINGRIX, the patient experienced fever, bedridden, sickness and influenza-like symptoms. In June 2018, the patient experienced hair loss. In April 2018, the outcome of the fever, bedridden, sickness and influenza-like symptoms were recovered/resolved. On an unknown date, the outcome of the hair loss was recovering/resolving. The reporter considered the fever, hair loss, bedridden and sickness to be related to SHINGRIX. It was unknown if the reporter considered the influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient. The patient was healthy. The patient's physician recommended that the patient should receive SHINGRIX as she was over the age of 50. At pharmacy, where she received vaccine, the patient was warned about the possible side effects were redness and soreness at the injection site for a day or two. The patient received SHINGRIX on the left arm. The patient experienced high fever and began to feel really sick in the night of vaccination day. The patient reported that she could not get out of bed. The patient was in bed for 3 days and was unable to function. The patient had these symptoms for three days and then they resolved. Three month after vaccination, approximately 1 month before the date of reporting, in June 2018, the patient experienced tragic loss of hair. The patient's hair started falling out like she had received radiation. The patient left that she had lost half of hair. The hair loss was slowing down at the time of reporting. The patient felt that all of the symptoms were related to the product. The patient went to her primary care physician as well as her dermatologist, both inquired whether she suffered any illness presenting with high fever 2 to 3 months prior to these symptoms. The patient then recalled that she did fall ill 3 months prior to the hair loss directly as a result of SHINGRIX. The patient's dermatologist told her it was related to the product. The patient's physician also ran a series of blood tests to see if it were possibly another cause. The blood test results were negative. Till the date of reporting, the patient lost 60 to 70 percent of the hair from her scalp. The patient was sure she would ever be restored. The reporter gave permission to contact her physician. The patient was very angry regarding the side effects she experienced and stated that neither the pharmacy nor her physician told her that she would experience any of these symptoms. The patient wanted GlaxoSmithKline to take responsibility for her experience and she contacted the legal department. The patient stated that she suffered greatly due to the company's negligence in properly warning of potential side effects. She expected to be compensated for her disfigurement a well as pain and suffering.